BRNS (Barinthus Biotherapeutics PLC) Sof foyda

BRNS (Barinthus Biotherapeutics plc) - kompaniyaning tovar belgisi

Barinthus Biotherapeutics (BRNS) Oxford bilan strategik ittifoqlardan foydalangan holda innovatsion saraton va gepatit vaksinalarini ishlab chiqadi. Yuqori patent to'siqlari va FDA ning qat'iy nazorati uning bozor pozitsiyalarini himoya qilishni ta'minlaydi. T-hujayrali terapiyani ishlab chiqish R&D muvaffaqiyatiga bog'liq. Ushbu grafikdagi kompaniyaning foydasi kapital samaradorligini namoyish etadi, bunda -0.04 belgisi joriy dinamikaning tegishli ko'rsatkichi bo'lib xizmat qiladi.

BRNS (Barinthus Biotherapeutics) Sof foyda tarixi 21.02.2024dan 19.09.2026gacha

Barinthus Biotherapeutics plc (BRNS) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Barinthus Biotherapeutics Corp|BRNS - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Barinthus Biotherapeutics Corp|BRNS - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Barinthus Biotherapeutics|BRNS - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi barinthusbio.com|BRNS - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Barinthus Biotherapeutics|BRNS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Barinthus Biotherapeutics PLC|BRNS - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Barinthus Biotherapeutics Corp|BRNS - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Barinthus Biotherapeutics|Shoshilinch likvidlik barinthusbio.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
BRNS - Sof foyda
Kompaniyaning jamlanma tahlili:Barinthus Biotherapeutics
Barinthus Bio asosiy tovari

Barinthus Biotherapeutics foydasi barcha operatsion va soliq xarajatlari chegirib tashlanganidan keyingi yakuniy moliyaviy natijani aks ettiradi va kapitalni boshqarish samaradorligining asosiy ko'rsatkichi bo'lib xizmat qiladi. Kompaniya tomonidan olingan foyda tahlili Barinthus Biotherapeutics ning pul oqimi barqarorligini baholash imkonini beradi, bu esa biotexnologiya sektorining makroiqtisodiy tebranishlardan yakkalanganligi va innovatsion tibbiy dori vositalariga doimiy talab tufayli barqaror qolmoqda.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|Intrexon - Sof foyda|PHAR: Kompaniyaning sof foydasi|NKTR: Sof foyda|upstreambio.com (UPB) - Sof foyda|Kompaniyaning sof foydasi Zenas Biopharma|IMNM: Yakuniy foyda|Sof foyda GOSS|Sof moliyaviy natija KalVista Corp|Kompaniyaning sof foydasi Septerna Inc SEPN|PVLA: Kompaniya foydasi|SVRA: Sof daromad|Rigel Pharma - Soliqlar to‘langandan keyingi foyda|ANAB: Sof foyda|Astria Corp - Yakuniy foyda|Sof daromad ENGN|Sof foyda rapt.com|Kompaniyaning sof foydasi Aerovate Therapeutics Inc (JBIO)|Sof moliyaviy natija Aclaris Therapeutics Inc.|Kyverna - Sof daromad|Yakuniy foyda TLSA|Cabaletta Bio, Inc. - Sof foyda|VTYX: Kompaniyaning sof foydasi|THTX: Sof foyda|AVTX - Sof moliyaviy natija|Kompaniyaning sof foydasi Eledon|Kompaniyaning sof daromadi Agenus, Inc AGEN|Sof daromad CLYM (Climb Bio Inc)|Soliqlar to‘langandan keyingi foyda ZURA|Sof foyda ATYR (aTyr Pharma)|Yakuniy foyda ADAG|Ikena Oncology, Inc. - Sof foyda|Kompaniyaning sof daromadi Shattuck Labs, Inc.|equilliumbio.com (EQ) - Kompaniyaning sof foydasi|Connect Biopharma Holdings Limited - Yakuniy foyda|IMUX (Immunic Therapeutics) - Sof foyda|Sof foyda Atara Biotherapeutics Inc|Kompaniyaning sof foydasi InflaRx N.V. (IFRX)|XFOR: Soliqdan keyingi foyda|Sof foyda ACET (Adicet Bio, Inc.)|Celularity Inc (CELU) - Kompaniyaning sof daromadi|INMB: Sof daromad|KZR - Sof foyda|SABS (SAB Biotherapeutics, Inc) - Sof daromad|AKTX: Soliqlar to‘langandan keyingi foyda|ENLV (Enlivex Therapeutics Ltd) - Sof foyda|Q32 Bio Corp (QTTB) - Sof moliyaviy natija|Sof foyda GOVX|Sof daromad Edesa Biotech Inc EDSA|Kompaniyaning sof foydasi iBio Corp IBIO|Sof moliyaviy natija Carisma Therapeutics Inc (CARM)|XTL Biopharmaceuticals - Sof foyda|BOLT: Kompaniyaning sof foydasi|hcwbiologics.com (HCWB) - Kompaniyaning sof foydasi|Aptevo Therapeutics Inc. - Yakuniy foyda|Kompaniyaning sof foydasi AIM ImmunoTech|Kompaniya foydasi ADTX (Aditxt Corp)|Kompaniyaning sof foydasi GRI Bio, Inc. (GRI)|Sof moliyaviy natija xortx.com|Kompaniyaning sof foydasi Vyome Holdings HIND|REVB (Revelation Biosciences Inc) - Soliqdan keyingi foyda|Indaptus - Sof foyda|Yakuniy foyda SCNI (BiondVax Pharmaceuticals)|CALI: Sof foyda|Affimed N.V. (AFMD) - Sof foyda|Kompaniyaning sof foydasi Allakos Inc|HOOK: Yakuniy foyda|Kompaniyaning sof foydasi IGM Biosciences, Inc. (IGMS)|Sof daromad iTeos Pharma ITOS|Sof foyda OCEA (Ocean Biomedical, Inc.)|Sof foyda tcbiopharm.com TCBP|THRD: Sof daromad